YKL-40 in pediatric asthma, MUC5B promoter polymorphism in idiopathic pulmonary fibrosis, and esmolol in septic shock.
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Washington University, St. Louis, Missouri.
Hrishikesh S
HS
Kulkarni
Robert D
RD
Guzy
Colleen
C
McEvoy
D054392:Adipokines / Q000097:blood*; D058671:Adrenergic beta-1 Receptor Antagonists / Q000008:administration & dosage*; D056151:Airway Remodeling / Q000502:physiology*; D001249:Asthma / Q000097:blood*; D015415:Biomarkers / Q000097:blood*; D005260:Female; D006133:Growth Substances / Q000097:blood*; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D054990:Idiopathic Pulmonary Fibrosis / Q000235:genetics* / Q000401:mortality*; D007249:Inflammation / Q000378:metabolism*; D037102:Lectins / Q000097:blood*; D008297:Male; D055257:Mucin-5B / Q000235:genetics*; D011110:Polymorphism, Genetic; D011412:Propanolamines / Q000008:administration & dosage*; D012772:Shock, Septic / Q000188:drug therapy*
D054392:Adipokines; D058671:Adrenergic beta-1 Receptor Antagonists; D015415:Biomarkers; D006133:Growth Substances; D037102:Lectins; D055257:Mucin-5B; D011412:Propanolamines